Are regulatory T-cells linked with aging?

被引:84
作者
Dejaco, Christian [1 ]
Duftner, Christina [1 ]
Schirmer, Michael [1 ]
机构
[1] Innsbruck Med Univ, Clin Dept Internal Med, Div Gen Internal Med, A-6020 Innsbruck, Austria
关键词
regulatory T-lymphocyte; aging; FOXP3; cellular senescence; thymus;
D O I
10.1016/j.exger.2006.01.008
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
There is increasing evidence for an active and 'dominant' tolerance mediated by regulatory T-cells. Out of these CD4(+) 'naturally occurring' regulatory T-cells (TREGs) are currently the main research focus in this field. TREGs exert their suppressive function in vitro in a contact-dependent manner and preferentially express high levels of CD25 and the forkhead and winged-helix family transcription factor forkhead box P3 (FOXP3). Age-related increment of the prevalences of CD4(+)CD25(hi) TREGs were described controversially, and whether such changes explain immune dysfunction in the elderly is still unclear. During aging thymic TREG output may decrease with significant loss of thymic capacity to generate new T-cells, and TREG homeostasis has been shown to be sustained by alternative pathways like peripheral generation of TREGs. An imbalance of TREG homeostasis would then predispose to immune dysfunction in aged individuals explaining their higher risk of immune-mediated diseases, cancer or infections. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:339 / 345
页数:7
相关论文
共 94 条
[61]   Effect of glatiramer acetate (Copaxone) on CD4+CD25high3 T regulatory cells and their IL-10 production in multiple sclerosis [J].
Putheti, P ;
Soderstrom, M ;
Link, H ;
Huang, YM .
JOURNAL OF NEUROIMMUNOLOGY, 2003, 144 (1-2) :125-131
[62]   Circulating CD4+CD25+ T regulatory cells are not altered in multiple sclerosis and unaffected by disease-modulating drugs [J].
Putheti, P ;
Pettersson, A ;
Soderstrom, M ;
Link, H ;
Huang, YM .
JOURNAL OF CLINICAL IMMUNOLOGY, 2004, 24 (02) :155-161
[63]   Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level [J].
Roncador, G ;
Brown, PJ ;
Maestre, L ;
Hue, S ;
Martínez-Torrecuadrada, JL ;
Ling, KL ;
Pratap, S ;
Toms, C ;
Fox, BC ;
Cerundolo, V ;
Powrie, F ;
Banham, AH .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2005, 35 (06) :1681-1691
[64]   Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses [J].
Sakaguchi, S .
ANNUAL REVIEW OF IMMUNOLOGY, 2004, 22 :531-562
[65]   Naturally arising Foxp3-expressing CD25+ CD4+ regulatory T cells in immunological tolerance to self and non-self [J].
Sakaguchi, S .
NATURE IMMUNOLOGY, 2005, 6 (04) :345-352
[66]   THE PROGRESSIVE DIFFERENTIATION OF PRIMED T-CELLS IS ASSOCIATED WITH AN INCREASING SUSCEPTIBILITY TO APOPTOSIS [J].
SALMON, M ;
PILLING, D ;
BORTHWICK, NJ ;
VINER, N ;
JANOSSY, G ;
BACON, PA ;
AKBAR, AN .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (04) :892-899
[67]   Homeostatic control of T-cell generation in neonates [J].
Schönland, SO ;
Zimmer, JK ;
Lopez-Benitez, CM ;
Widmann, T ;
Ramin, KD ;
Goronzy, JJ ;
Weyand, CM .
BLOOD, 2003, 102 (04) :1428-1434
[68]  
Seddiki N, 2005, BLOOD
[69]   Regulatory/suppressor T cells in health and disease [J].
Shevach, EM .
ARTHRITIS AND RHEUMATISM, 2004, 50 (09) :2721-2724
[70]  
SIEGMUND K, 2005, BLOOD